Campanella, Michelangelo

MC is an Italian born scientist who found home in the United Kingdom where he has been given the privilege of leading innovative programmes of research and mentoring students since he moved there as an EMBO/MARIE CURIE PostDoctoral Research Fellow in 2005.
Trained as a Pharmacologist, he developed technical knowledge and comprehensive cultural proficiency to run innovative assays in living cells by obtaining a PhD on mitochondrial cell signalling completed in 2005. He is indeed conversant in many of the standard in vitro and in vivo techniques for the investigation of vital parameters in cells spanning from the imaging to the luminescent-based protocols together with standard approaches of molecular biology and biochemistry.
Internationally acknowledged as an expert in the field of mitochondrial cell biology and pharmacology he is now a Group Leader of the UCL Consortium for Mitochondrial Research and Tenured Reader of the Royal Veterinary College Department of Comparative Biomedical Sciences, which he joined as Faculty in 2008.
The core of his research focuses on the mitochondrial cell biology and quality control regulation in mammals and organism models, with particular attention to the mechanisms underlying cell pathology and inflammation. His scientific breakthroughs regard the hidden pathways of the fundamental homeostatic function of mitochondria and their pharmacological targeting.
Educated amid Italy, USA and the United Kingdom, he is now member of the scientific panel of the British Research Council (BBSRC) and chairman of the BBSRC industrial CASE (iCASE) studentships of the London Doctoral Training Program. He is also covering the role of Ambassador of the Biochemical Society and he is Visiting Professor of the University of Rome “TorVergata”.
His research activities are supported by the most prestigious funding organizations, which have played an instrumental role for his consolidation as leader in his field of research. He holds membership of Editorial Boards of eminent scientific publishers (e.g. Nature, Cell) and for the most prestigious of those regularly publishes original manuscripts as well as overview or commentaries. The abnegation to biomedical research, academic education and the service towards talented scholars in disadvantageous conditions has recently yielded me a Paul Harris Fellowship by the Rotary International Foundation in 2014.